FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 353:2636-2637 December 22, 2005 Number 25 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Perspective by Moscona, A. Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear PubMed Citation

"Doctor, I need a prescription for that bird flu drug." If recent newspaper headlines are any indication,¹ this request has been repeated tens of thousands of times around the country this fall. So much oseltamivir (Tamiflu) has been prescribed — presumably for personal stockpiling in case of an avian influenza pandemic, given that the human influenza season has not yet begun — that at the end of October, the drug's manufacturer stopped shipping it to the United States.

A busy outpatient office is no place to think through complicated ethical dilemmas. But a request for oseltamivir is just that, and . . . [Full Text of this Article]

Source Information

Dr. Brett is a professor of medicine at the University of South Carolina School of Medicine, Columbia; Dr. Zuger is an internist and infectious-disease specialist at St. Luke's–Roosevelt Hospital Center, New York.

This article has been cited by other articles:

• Nicoll, A (2008). Children, avian influenza H5N1 and preparing for the next pandemic. Arch. Dis. Child. 93: 433-438 [Abstract] [Full Text]  
• Curtis, N., Pollard, A. J (2007). Physicians' perception of pandemic influenza. Arch. Dis. Child. 92: 938-938 [Full Text]  
• Weinstock, D. M., Zuccotti, G. (2006). Adamantane Resistance in Influenza A. JAMA 295: 934-936 [Full Text]